The Organ Transplant System Improvement Act
Memo: Submitted to Staff of the U.S. Senate Committee on Finance
Population Health
Policy
Patient Focused Drug Development: Methodologic and Other Challenges Related to Patient Experience Data
Comment: Submitted to the Food and Drug Administration and Department of Health and Human Services
Print:
On December 18, 2024, LDI Senior Fellow Sean Hennessy, PharmD, PhD submitted a comment in response to a Request for Comments from the U.S Food and Drug Administration and U.S. Department of Health and Human Services. The request sought input regarding methodological challenges related to data on patient experience.
As an expert in pharmacoepidemiology, the study of the health effects of drugs and other medical products in populations, Dr. Hennessy provides 10 suggestions for improving the use of patient experience data in patient focused drug development.
Views expressed by the researchers are their own and do not necessarily represent those of the University of Pennsylvania Health System (Penn Medicine) or the University of Pennsylvania.
More on Policy at LDI
Optimizing Health Care for the Maternal-Infant Dyad
Memo: Delivered to the Office of Pennsylvania State Senator Maria Collett
The State of Philadelphia’s Reproductive Health Care System: Hispanic and Latine Women’s Health
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services
The State of Philadelphia’s Reproductive Health Care System: The Reproductive Health Safety Net
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services
Medicare and Medicaid Programs; Repeal of Minimum Staffing Standards for Long-Term Care Facilities
Comment: Submitted to Centers for Medicare & Medicaid Services
Dually Eligible Medicare and Medicaid Beneficiaries Enrolled in a Chronic Condition Special Needs Plan (C-SNP)
Comment: Delivered to the Centers for Medicare & Medicaid Services (CMS)